{
    "eu_accel_assess_g": "__SCRAPER_NOT_FOUND__",
    "eu_od_date": "__SCRAPER_NOT_FOUND__",
    "assess_time_days_total": -1,
    "eu_od_pnumber": "__SCRAPER_NOT_FOUND__",
    "active_substance": [
        "axicabtagene ciloleucel",
        "0001-01-01"
    ],
    "assess_time_days_active": -1,
    "eu_od_sponsor": "__SCRAPER_NOT_FOUND__",
    "eu_aut_status": "ACTIVE",
    "eu_od_comp_date": "__SCRAPER_NOT_FOUND__",
    "eu_brand_name_current": [
        {
            "value": "Yescarta",
            "date": "22/12/2022"
        }
    ],
    "assess_time_days_cstop": -1,
    "eu_prime_initial": {
        "value": "__SCRAPER_NOT_FOUND__",
        "date": "0001-01-01"
    },
    "ema_corapp": "__SCRAPER_NOT_FOUND__",
    "eu_indication_initial": {
        "value": "yescarta is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) and primary mediastinal large b-cell lymphoma (pmbcl), after two or \n more lines of systemic therapy.\n",
        "date": "0001-01-01"
    },
    "ec_decision_time_days": -1,
    "eu_od_con": "__SCRAPER_NOT_FOUND__",
    "eu_od_initial": {
        "value": "adopted",
        "date": "0001-01-01"
    },
    "ema_reexamination": "__SCRAPER_NOT_FOUND__",
    "eu_aut_date": "2018-08-23",
    "ema_omar_condition": "__SCRAPER_NOT_FOUND__",
    "atc_code": "__SCRAPER_NOT_FOUND__",
    "eu_orphan_con_current": [
        {
            "value": [
                {
                    "pre": "o",
                    "id": "1393",
                    "eu_num": "EU/3/14/1393",
                    "indication": "Treatment of diffuse large B cell lymphoma",
                    "link_date": "2018-08-27"
                },
                {
                    "pre": "o",
                    "id": "1553",
                    "eu_num": "EU/3/15/1553",
                    "indication": "Treatment of primary mediastinal large B-cell lymphoma",
                    "link_date": "2018-08-27"
                },
                {
                    "pre": "o",
                    "id": "1579",
                    "eu_num": "EU/3/15/1579",
                    "indication": "Treatment of follicular lymphoma",
                    "link_date": "2022-06-23"
                }
            ],
            "date": "22/12/2022"
        }
    ],
    "eu_aut_type_initial": {
        "value": "__SCRAPER_NOT_FOUND__",
        "date": "0001-01-01"
    },
    "chmp_opinion_date": "__SCRAPER_NOT_FOUND__",
    "eu_referral": "False",
    "eu_procedures_todo": [
        {
            "eu_referral": false,
            "eu_suspension": false
        }
    ],
    "eu_aut_type_current": [
        {
            "value": "standard",
            "date": "22/12/2022"
        }
    ],
    "ema_rapp": "__SCRAPER_NOT_FOUND__",
    "eu_pnumber": "EU/1/18/1299",
    "eu_brand_name_initial": {
        "value": "Yescarta",
        "date": "0001-01-01"
    },
    "eu_suspension": "False",
    "orphan_status": "h",
    "eu_legal_basis": "__SCRAPER_NOT_FOUND__",
    "ema_number": "EMEA/H/C/004480",
    "aut_url": "404_url_not_found",
    "ema_number_id": "4480",
    "omar_url": "404_url_not_found",
    "smpc_url": "404_url_not_found",
    "ema_number_certainty": "0.625",
    "epar_url": "404_url_not_found",
    "ema_number_check": [
        false,
        "22/12/2022"
    ],
    "odwar_url": "404_url_not_found",
    "eu_mah_current": [
        {
            "value": "Kite Pharma EU B.V.",
            "date": "22/12/2022"
        }
    ],
    "eu_od_number": "__SCRAPER_NOT_FOUND__",
    "eu_atmp": true,
    "eu_mah_initial": {
        "value": "Kite Pharma EU B.V.",
        "date": "0001-01-01"
    },
    "eu_nas": true,
    "ema_od_number": "__SCRAPER_NOT_FOUND__",
    "ema_procedure_start_initial": "__SCRAPER_NOT_FOUND__",
    "eu_med_type": [
        "small molecule",
        "0001-01-01"
    ]
}